Autologous Peripheral Blood Stem Cell Transplantation for Adults with B-Lineage Acute Lymphoblastic Leukemia: A Pilot Study

References

• Hoelzer D., Thiel E., Löffler H., Bodenstein H., Plaumann L., Büchner T., Urbanitz D., Koch I., Heimpel H., Engel-hardt R., Müller U., Wendt E. C., Sodomann H., Rühl H., Herrmann E., Kaboth W., Dietzfelbinger H., Prallel H., Lunscken C., Hellriegel K. P., Spors S., Nowrousian R. M., Fischer J., Fülle H., Mitrou P. S., Pfreundschhuh M., Görg C., Emmerich B., Queisser W., Meyer P., Labedzki L., Ess-ers U., König H., Mainzer K., Herrmann R., Messerer D., Zwingers T. Intensified therapy in acute lym-phoblastic and acute undifferentiated leukemia in adults. Blood. 1984; 64: 38–47
   PubMed Web of Science ®Google Scholar
• Gottlieb A. J., Weinberg V., Ellison R. R., Henderson E. S., Terebelo H., Rafla S., Cuttner J., Silver R. T., Carey R. W., Levy R. N., Hutchinson J. L., Raich P., Cooper M. R., Wiemik P., Anderson J. R., Holland J. F. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood 1984; 64: 267–274
   PubMed Web of Science ®Google Scholar
• Burnett A. K., Eden O. B. The treatment of acute leukaemia. The Lancer 1997; 349: 270–275
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Walters R. S., Keating M. J., Smith T. L., O'Brien S., Estey E. H., Huh Y. O., Spinolo J., Dicke K., Barlogie B., McCredie K. B., Freireich E. L. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J. Clin. Oncol. 1990; 8: 994–1004
   PubMed Web of Science ®Google Scholar
• Wemli M., Tichelli A., von Fliedner V., Brun del Re G., Chapuis B., Fey M. F., Fopp M., Gmür J., Grob J. P., Jacky E., Pedrazzini A., Schmid L., Senn H. J., Tobler A., Gratwohl A. Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. B, J. Haematol. 1994; 87: 39–43
   PubMed Web of Science ®Google Scholar
• Weisdorf D. J., Nesbit M. E., Ramsay N. K., Woods W. G., Goldman A. I., Kim T. H., Hurd D. D., McGlave P. B., Kersey J. H. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J. Clin. Oncol. 1987; 5: 1348–1355
   PubMed Web of Science ®Google Scholar
• Doney K., Fisher L. D., Appelbaum F. R., Buckner C. D., Storb R., Singer J., Fefer A., Anasetti C., Beatty P., Bens-inger W., Clift R., Hansen J., Hill R., Loughran T. P., Jr, Martin P., Petersen F. B., Sanders J., Sullivan K. M., Stewart P., Weiden R., Witherspoon R., Thomas E. D. Treatment of adult acute lymphoblastic leukemia with allo-geneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone. Marrow. Transplant. 1991; 7: 453–459
   PubMed Web of Science ®Google Scholar
• Horowitz M. M., Messerer D., Hoelzer D., Gale R. P., Neiss A., Atkinson K., Barrett J., Büchner T., Freund M., Heil G., Hiddemann W., Kolb H. J., Löffler H., Marmont A. M., Maschmeyer G., Rimm A. A., Rpzman C., Sobocin-ski K. A., Speck B., Thiel E., Weisdorf D. J., Zwaan F. E., Bortin M. M. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann. Intern. Med. 1991; 115: 13–18
   PubMed Web of Science ®Google Scholar
• Weisdorf D. J., Woods W. G., Nesbit M. E., Jr, Uckun F., Dusenbery K., Kim T., Haake R., Thomas W., Kersey J. H., Ramsay N. K. Allogeneic bone marrow transplantation for acute ymphoblastic leukaemia: risk factors and clinical outcome. Br. J. Haematol. 1994; 86: 62–69
   PubMed Web of Science ®Google Scholar
• To L. B., Haylock D. N., Simmons P. J., Juttner C. A. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233–2258
   PubMed Web of Science ®Google Scholar
• Takaue Y., Watanabe A., Murakami T., Watanabe T., Kawano Y., Kuroda Y., Matsushita T., Kikuta A., Kosaka Y., Kudo T., Shimizu H., Koizumi S., Fujimoto T. High-dose chemotherapy and blood stem cell autografts for children with first relapsed acute lymphoblastic leukemia: a pilot study of the Children's Cancer and Leukemia Study Group of Japan (CCLSG). Med. Pediatr. Oncol. 1994; 23: 20–25
   PubMedGoogle Scholar
• Takaue Y., Watanabe T., Hoshi Y., Abe T., Matsunaga K., Saito S., Hirao A., Kawano Y., Ninomiya T., Kuroda Y., Koyama T., Suzue T., Shimokawa T., Uchiyama H., Watanabe A., Matsushita T., Kikuta A., Yokobayashi A., Murakami R., Manabe A., Hosoya R., Ohira M., Fujimoto T. Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features. Cancer 1991; 67: 1830–1837
   PubMed Web of Science ®Google Scholar
• Muroi K., Nakamura M., Amemiya Y., Suda T., Miura Y. Expression of c-kit receptor (CDI17) and CD34 in leukemic cells. Leuk. Lymphoma. 1995; 16: 297–305
   PubMed Web of Science ®Google Scholar
• Copelan E. A., McGuire E. A. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151–1168
   PubMed Web of Science ®Google Scholar
• Schauer P., Arlin Z. A., Mertelsmann R., Cirrincione C., Friedman A., Gee T. S., Dowling M., Kempin S., Straus D. J., Koziner B., McKenzie S., Thaler Tzvi H., Dufour P., Little C., Dellaquila C., Ellis S., Clarkson B. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-IOM protocols. J. Clin. Oncol. 1993; 8: 462–470
   Google Scholar
• Suzuki T., Muroi K., Amemiya Y., Miura Y. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system. Bone Marrow Transplant. 1998; 21: 751–757
   PubMed Web of Science ®Google Scholar
• Dekker A. W., van't Veer M. B., Sizoo W., Haak H. J., van der Lelie J., Ossenkoppele G., Huijgens P. C., Schouten H. C., Sonneveld P., Willemze R., Verdonck L. F., van Putten W. L., Löwenberg B. Intensive postremis-sion chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. J. Clin. Oncol. 1997; 15: 476–482
   PubMed Web of Science ®Google Scholar
• Doney K., Fisher L. D., Appelbaum F. R., Buckner C. D., Storb R., Singer J., Fefer A., Anasetti C., Beatty P., Bens-inger W., Clift R., Hansen J., Hill R., Loughran T. P., Jr, Martin P., Petersen F. B., Sanders J., Sullivan K. M., Stewart P., Weiden P., Witherspoon R., Thomas E. D. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone. Marrow. Transplant. 1991; 7: 453–459
   PubMed Web of Science ®Google Scholar
• Sebban C., Lepage E., Vernant J. P., Gluckman E., Attal M., Reiffers J., Sutton L., Racadot E., Michallet M., Mara-ninchi D., Drefus F., Fiere D. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J. Clin. Oncol. 1994; 12: 2580–2587
   PubMed Web of Science ®Google Scholar
• De Witte T., Awwad B., Boezeman J., Schattenberg A., Muus P., Raemaekers J., Preijers F., Strijckmans P., Haanen C. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone. Marrow. Transplant. 1994; 14: 767–774
   PubMed Web of Science ®Google Scholar
• Oh H., Gale R. P., Zhang M. J., Passweg J. R., Ino T., Murakami H., Ohno R., Rowlings P. A., Sobocinski K. A., Tanimoto M., Tomonaga M., Weisdorf D. J., Horowitz M. M. Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. Bone. Marrow. Transplant. 1998; 22: 253–251
   PubMed Web of Science ®Google Scholar
• Barrett A. J., Horowitz M. M., Ash R. C., Atkinson K., Gale R. P., Goldman J. M., Henslee-Downey P. J., Herzig R. H., Speck B., Zwaan F. E., Bortin M. M. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067–3070
   PubMed Web of Science ®Google Scholar
• Weisdorf D. J., Billett A. L., Hannan P., Ritz J., Sallan S. E., Steinbuch M., Ramsay N. K. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997; 90: 2962–2968
   PubMed Web of Science ®Google Scholar
• Fiere D., Lepage E., Sebban C., Boucheix C., Gisselbre-cht C., Vemant J. P., Varet B., Broustet A., Cahn J. Y., Rigal-Huguet F., Witz F., Michaux J. L., Michallet M., Reiffers J. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. J. Clin. Oncol. 1993; 11: 1990–2001
   PubMed Web of Science ®Google Scholar
• Zhang M. J., Hoelzer D., Horowitz M. M., Gale R. P., Messerer D., Klein J. P., Löffler H., Sobocinski K. A., Thiel E., Weisdorf D. J. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. Ann. Intern. Med. 1995; 123: 428–431
   PubMed Web of Science ®Google Scholar
• Bassan R., Lerede T., Bona E. D., Rambaldi A., Rossi G., Pogliani E., Oriani A., D'Emilio A., Izzi T., Lam-bertenghi-Deliliers G., Comeo G., Barbui T. Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft. and post-graft chemotherapy in adult acute lymphoblastic leukaemia. Br. J. Haematol. 1999; 104: 755–762
   PubMed Web of Science ®Google Scholar
• Powles R., Mehta J., Singhal S., Horton C., Tait D., Milan S., Pollard C., Lumley H., Matthey F., Shirley J., Williams H., Samaratunga I., Lakhani A., Millar J., Treleaven J. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant. 1995; 16: 241–241
   PubMed Web of Science ®Google Scholar
• Seriu T., Yokota S., Nakao M., Misawa S., Takaue Y., Koizumi S., Kawai S., Fujimoto T. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 1995; 9: 615–623
   PubMed Web of Science ®Google Scholar
• Bender J. G., Williams S. F., Myers S., Nottleman D., Lee W. J., Unverzagt K. L., Walker D., To L. B., van Epps D. E. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant. 1992; 10: 281–285
   PubMed Web of Science ®Google Scholar